These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 36649876)

  • 1. Interaction between endothelial cell-derived extracellular vesicles and monocytes: A potential link between vascular thrombosis and pregnancy-related morbidity in antiphospholipid syndrome.
    Álvarez D; Morales-Prieto DM; Cadavid ÁP
    Autoimmun Rev; 2023 Apr; 22(4):103274. PubMed ID: 36649876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extracellular Vesicles and Antiphospholipid Syndrome: State-of-the-Art and Future Challenges.
    Štok U; Čučnik S; Sodin-Šemrl S; Žigon P
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiphospholipid Syndrome in Pregnancy: New and Old Pathogenetic Mechanisms.
    D'Ippolito S; Barbaro G; Paciullo C; Tersigni C; Scambia G; Di Simone N
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular Vesicles in the Antiphospholipid Syndrome.
    Chaturvedi S; Alluri R; McCrae KR
    Semin Thromb Hemost; 2018 Jul; 44(5):493-504. PubMed ID: 28476065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiphospholipid-exposed trophoblast-derived extracellular vesicles express elevated levels of TLR7/8-activating microRNAs and induce endometrial endothelial activation, in part, through TLR7.
    Coenen CS; Hidalgo TN; Lynn T; Jones DM; Salmon JE; Chamley LW; Abrahams VM
    J Reprod Immunol; 2024 Aug; 164():104255. PubMed ID: 38797133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small-Extracellular-Vesicle-Derived miRNA Profile Identifies miR-483-3p and miR-326 as Regulators in the Pathogenesis of Antiphospholipid Syndrome (APS).
    Solé C; Royo M; Sandoval S; Moliné T; Cortés-Hernández J
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma microparticle tissue factor activity in patients with antiphospholipid antibodies with and without clinical complications.
    Willemze R; Bradford RL; Mooberry MJ; Roubey RA; Key NS
    Thromb Res; 2014 Feb; 133(2):187-9. PubMed ID: 24332063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of Plasma-Derived Small Extracellular Vesicles Indicates Ongoing Endothelial and Platelet Activation in Patients with Thrombotic Antiphospholipid Syndrome.
    Štok U; Blokar E; Lenassi M; Holcar M; Frank-Bertoncelj M; Erman A; Resnik N; Sodin-Šemrl S; Čučnik S; Pirkmajer KP; Ambrožič A; Žigon P
    Cells; 2020 May; 9(5):. PubMed ID: 32414170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of immunothrombosis and vasculopathy in antiphospholipid syndrome.
    Knight JS; Kanthi Y
    Semin Immunopathol; 2022 May; 44(3):347-362. PubMed ID: 35122116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microparticles: An Alternative Explanation to the Behavior of Vascular Antiphospholipid Syndrome.
    Álvarez D; Rúa C; Cadavid J ÁP
    Semin Thromb Hemost; 2021 Oct; 47(7):787-799. PubMed ID: 33930895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiphospholipid syndrome - an update.
    Linnemann B
    Vasa; 2018 Oct; 47(6):451-464. PubMed ID: 30205764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyroptosis-triggered pathogenesis: New insights on antiphospholipid syndrome.
    Tan Y; Liu Q; Li Z; Yang S; Cui L
    Front Immunol; 2023; 14():1155222. PubMed ID: 37063905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome.
    Oku K; Amengual O; Atsumi T
    Eur J Clin Invest; 2012 Oct; 42(10):1126-35. PubMed ID: 22784367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing antiphospholipid-mediated thrombosis: the interplay between anticardiolipin antibodies and endothelial cells.
    Pierangeli SS; Harris EN
    Lupus; 2003; 12(7):539-45. PubMed ID: 12892395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome?
    Chayoua W; Yin DM; Kelchtermans H; Moore GW; Gris JC; Musiał J; Zuily S; Ten Cate H; de Laat B; Devreese KMJ
    Thromb Haemost; 2020 Nov; 120(11):1557-1568. PubMed ID: 32696448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches.
    Lopez-Pedrera C; Barbarroja N; Patiño-Trives AM; Collantes E; Aguirre MA; Perez-Sanchez C
    Front Immunol; 2019; 10():764. PubMed ID: 31040845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study.
    de Jesús GR; Sciascia S; Andrade D; Barbhaiya M; Tektonidou M; Banzato A; Pengo V; Ji L; Meroni PL; Ugarte A; Cohen H; Branch DW; Andreoli L; Belmont HM; Fortin PR; Petri M; Rodriguez E; Cervera R; Knight JS; Atsumi T; Willis R; Nascimento IS; Rosa R; Erkan D; Levy RA;
    BJOG; 2019 Apr; 126(5):656-661. PubMed ID: 30222236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis in monocytes of antiphospholipid syndrome patients: deregulation of proteins related to the development of thrombosis.
    López-Pedrera C; Cuadrado MJ; Herández V; Buendïa P; Aguirre MA; Barbarroja N; Torres LA; Villalba JM; Velasco F; Khamashta M
    Arthritis Rheum; 2008 Sep; 58(9):2835-44. PubMed ID: 18759277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients.
    Li C; Zuo Y; Zhang S; Makris UE; Karp DR; Li Z
    Chin Med J (Engl); 2022 Mar; 135(6):658-664. PubMed ID: 35143425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in Endothelial Activation and Dysfunction Induced by Antiphospholipid Antibodies Among Groups of Patients With Thrombotic, Refractory, and Non-refractory Antiphospholipid Syndrome.
    Velásquez M; Peláez LF; Rojas M; Narváez-Sánchez R; Velásquez JA; Escudero C; San Martín S; Cadavid ÁP
    Front Physiol; 2021; 12():764702. PubMed ID: 34925061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.